about
Mixed-lineage kinase 3 delivers CD3/CD28-derived signals into the IkappaB kinase complexFOXO1 downregulation contributes to the oncogenic program of primary mediastinal B-cell lymphoma.Activation of oncogenic pathways in classical Hodgkin lymphoma by decitabine: A rationale for combination with small molecular weight inhibitors.Effects of complete and incomplete tumor promoters on hair growth, angiogenesis, and tenascin expression in the skin of NMRI mice.Repression of TCF3/E2A contributes to Hodgkin lymphomagenesis.FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma.Decitabine represses translocated MYC oncogene in Burkitt lymphoma.FOXO1 is a tumor suppressor in classical Hodgkin lymphoma.KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.Enriching suicide gene bearing tumor cells for an increased bystander effect.Downregulation of internal enhancer activity contributes to abnormally low immunoglobulin expression in the MedB-1 mediastinal B-cell lymphoma cell line.Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression.Targeting the intratumor heterogeneity in PMBL.Inhibition of nitric-oxide-mediated apoptosis in Jurkat leukemia cells despite cytochrome c release.TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway.N-myc augments death and attenuates protective effects of Bcl-2 in trophically stressed neuroblastoma cells.Expression of constitutively active FoxO3 in murine forebrain leads to a loss of neural progenitors.Nitric oxide-mediated apoptosis in human breast cancer cells requires changes in mitochondrial functions and is independent of CD95 (APO-1/Fas).Glutathione is a factor of resistance of Jurkat leukemia cells to nitric oxide-mediated apoptosis.Growth inhibition of murine neuroblastoma cells by C-Myc with cell cycle arrest in G2/M[The effect of a synthetic fragment of human interleukin-2 on the growth and vascularization of sarcoma 180 in mice]Modulation of KB and A431 cell adhesion by epidermal growth inhibitory pentapeptideGrowth-stimulating phase of macrophage response to activation: the phenomenon and its implications for tumour growth and immunotherapy[The prospects for using nonsteroidal anti-inflammatory agents in the treatment of malignant neoplasms][Angiogenesis as a target for antitumor actions][Technology of liquid dosing]The synthetic peptide related to the central part of human interleukin-2 molecule accelerates growth and vascularization of sarcoma 180 in miceNitric-oxide-induced apoptosis in human leukemic lines requires mitochondrial lipid degradation and cytochrome C releaseDifferential reconstitution of mitochondrial respiratory chain activity and plasma redox state by cysteine and ornithine in a model of cancer cachexiaABF-1 is frequently silenced by promoter methylation in follicular lymphoma, diffuse large B-cell lymphoma and Burkitt's lymphomaFOXO1 Confers Maintenance of the Dark Zone Proliferation and Survival Program and Can Be Pharmacologically Targeted in Burkitt LymphomaPhysiological levels of the PTEN-PI3K-AKT axis activity are required for maintenance of Burkitt lymphoma
P50
Q24554281-6F6B40CD-6CC5-4F4E-9A84-A37BA6C16AE6Q34221760-827BF9C5-56C4-4F4A-A4A1-DDF37DCE7399Q36236109-835107DC-AF51-4210-B66C-9D3384B4B154Q36676898-8BDB3B21-49A8-420E-8B18-9EF14C8DB5E5Q37392856-D2C6981D-31A2-4263-8541-7948457A671FQ38955441-CA11320A-B696-4154-AEA2-536C7CA56216Q39206395-A7FAC060-8F35-4629-9308-5744A1D8B761Q39394904-EFDF4E9F-BD32-42B2-8258-075D6046CEE5Q39697163-C20A21D7-8303-4300-B5B3-0ACEF8ABB4C7Q40223019-4C8D0083-C417-4921-982F-A74E6212F877Q40463591-A51CF1A3-195A-4280-951C-5DBDFB0EA9B4Q40530253-4F84A29F-D2E4-4599-B394-F3963A76B86AQ42782702-A166C6EC-C3ED-42EF-8FC2-6CCD7B23B191Q43575272-3A7DB3BE-FFA9-49B3-B262-6E2D800A3E82Q46275181-AC357BC4-20CC-43A3-9554-F9B2680BC2AFQ46809713-9C1B0FC0-D57A-4372-888D-FD2577A45690Q48393694-B2D81299-573C-4522-817D-4F02EE20CD4EQ52537368-27705842-3AFF-4DC1-A804-6F7ED5C09E4CQ54047524-B7DA64EA-4B4A-4FE6-9950-5EDE4402D573Q57384591-A056F03F-3E32-4F06-BBCD-FA70D6DD107EQ67715636-C7AE67C8-EABC-49F0-9132-000DD4DFDF70Q67887954-4DEB6E85-6CF5-4377-959F-61389D846B75Q68195682-FD29D8DE-B4E6-41F3-A580-9AF859107D7FQ68621370-5FEA5830-FF0C-44E6-B292-01EEAC6906D5Q69060449-7524FCAF-559E-42FF-BD9C-56155DC9576BQ73198275-7BBDE6AA-181E-412C-A97C-99E70D42C631Q74244559-7D55A49C-7F66-4DA9-B474-5F9960B2E275Q74632740-DD1CE540-26D9-45B6-8637-F536C4D0EE8DQ78029758-81C2FD08-7CBC-4CB9-9408-703179A99A22Q80960470-4412F0F3-3C3A-4876-AB15-D14C2BACDEA6Q90311439-52B1A409-8C62-417A-AFD6-2BBDF657B203Q91260581-50DC34EC-F40A-40A5-A0B2-D88D2261CB41
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alexey Ushmorov
@ast
Alexey Ushmorov
@en
Alexey Ushmorov
@es
Alexey Ushmorov
@nl
type
label
Alexey Ushmorov
@ast
Alexey Ushmorov
@en
Alexey Ushmorov
@es
Alexey Ushmorov
@nl
prefLabel
Alexey Ushmorov
@ast
Alexey Ushmorov
@en
Alexey Ushmorov
@es
Alexey Ushmorov
@nl
P106
P21
P31
P496
0000-0003-3724-7253